Erythromycin base is poorly acid-stable, reducing oral absorption. Salts like stearate improve stability and absorption. Esters, such as ethylsuccinate, enhance taste and absorption. Choice depends on infection site, stability needs, and patient tolerance.

Erythromycin base degrades in stomach acid, posing absorption issues. Its salts (e.g., ethylsuccinate) have better stability and oral uptake. Esters focus on specific uptake paths enhancing bioavailability. Selection varies with infection location and patient compliance.

While erythromycin base is less stable in acid, resulting in variable absorption, its esters, like ethylsuccinate, are designed for better gastric survival and absorption. Salts such as stearate also offer improved stability. Choice of form should consider infection specifics and patient needs.

The base form of erythromycin is less stable in acidic environments, affecting absorption. Erythromycin salts, such as stearate, are more stable and absorb better. Esters are tailored for specific absorption pathways, impacting clinical efficacy. Treatment specifics dictate the form used.